Free shipping on all orders over $ 500

Zalcitabine

Cat. No. M3347
Zalcitabine Structure
Synonym:

ddC; Dideoxycytidine; 2',3'-Dideoxycytidine

Size Price Availability Quantity
50mg USD 50  USD50 In stock
100mg USD 70  USD70 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Zalcitabine is a nucleoside analog reverse transcriptase inhibitor (NARTI).Zalcitabine is an analog of pyrimidine. It is a derivative of the naturally existing deoxycytidine, made by replacing the hydroxyl group in position 3’ with a hydrogen.It is phosphorylated in T cells and other HIV target cells into its active triphosphate form, ddCTP. This active metabolite works as a substrate for HIV reverse transcriptase, and also by incorporation into the viral DNA, hence terminating the chain elongation due to the missing hydroxyl group. Since zalcitabine is a reverse transcriptase inhibitor it possess activity only against retroviruses.

Chemical Information
Molecular Weight 211.22
Formula C9H13N3O3
CAS Number 7481-89-2
Solubility (25°C) DMSO 40 mg/mL
Water ≥ 35 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Antn L Martnez, et al. Identification of Novel Regulators of Zalcitabine-Induced Neuropathic Pain

[2] J C Adkins, et al. Zalcitabine. An update of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of HIV infection

[3] M J Shelton, et al. Zalcitabine

[4] J J Lipsky. Zalcitabine and didanosine

[5] D Devineni, et al. Zalcitabine. Clinical pharmacokinetics and efficacy

Related Reverse Transcriptase Products
Fosalvudine tidoxil

Fosalvudine tidoxil is an orally active nucleoside reverse transcriptase inhibitor (NRTI).

Emtricitabine triphosphate tetrasodium salt

Emtricitabine triphosphate tetrasodium salt is the tetrasodium salt form of Emtricitabine triphosphate and a nucleoside reverse transcriptase inhibitor (NRTI) targeting HIV and HBV.

M-MLV Reverse transcriptase

M-MLV Reverse transcriptase (M-MLV RT) is a kind of Reverse transcriptase, from the moroni mouse leukemia virus (MoMLV).

ddUTP

ddUTP (2′,3′-Dideoxyuridine-5′-triphosphate) is a selective HIV and AMV reverse transcriptase inhibitor with Ki values of 0.05 µM and 1 µM, respectively.

Rovafovir etalafenamide

Rovafovir etalafenamide (GS-9131), a proagent of the adenosine nucleotide analogue GS-9148, is an orally active nucleoside reverse transcriptase inhibitor (NRTI). Rovafovir etalafenamide is potent and active against a variety of NRTI mutants, and shows potent anti-HIV-1 activity.

  Catalog
Abmole Inhibitor Catalog




Keywords: Zalcitabine, ddC; Dideoxycytidine; 2',3'-Dideoxycytidine supplier, Reverse Transcriptase, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.